Edwards Lifesciences

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Edwards Lifesciences sits in the top decile of US sponsors by registered trial count (#343 of 15,742 sponsors by registered trial count).

57 total trials 10 currently recruiting 22 completed top decile by trial count

Edwards Lifesciences: 57 sponsored US clinical trials, 10 recruiting.

Edwards Lifesciences sponsors 57 registered US clinical trials on ClinicalTrials.gov, 10 of them currently recruiting, and 22 completed. The most-studied condition in this pipeline is Heart Failure, with 5 trials.

Top-decile sponsor footprint

Edwards Lifesciences ranks in the top decile of sponsors by registered trial count (#343 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 60/100

22 of 25 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

What is open in the Edwards Lifesciences pipeline

10 recruiting of 57 indexed (18% open); 22 completed (39%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Heart Failure (5 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Edwards Lifesciences: open-pipeline peers nationwide

Peers matched on 57 registered trials and 18% open enrollment, not the therapeutic-area sidebar.

Edwards Lifesciences sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,5002,000 0%5%10%15%20% Total trials Recruiting share Edwards LifesciencesSt. Luke's-Roosevelt Hospital CenterSupernus PharmaceuticalsUSDA Grand Forks Human Nutrition Research CenterEast Carolina UniversityIndiana UniversityUniversity of California, Los AngelesUniversity of South FloridaVA Office of Research and Development
Edwards Lifesciences sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Edwards Lifesciences sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 57 trials (± recruiting share)

Sponsors near 18% open enrollment (± trial volume)

What to do with this Edwards Lifesciences page

57 registered trials is a research-attention snapshot, not an endorsement of Edwards Lifesciences or any single study.

  • 10 of Edwards Lifesciences's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Heart Failure is the condition Edwards Lifesciences studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Heart Failure trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Edwards Lifesciences pipeline card: 57 registered trials from official public datasets.Report a data error.